Recent developments on therapeutic and diagnostic approaches for COVID-19
J Majumder, T Minko - The AAPS journal, 2021 - Springer
The ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has made a serious public health …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has made a serious public health …
[HTML][HTML] Role of favipiravir in the treatment of COVID-19
S Joshi, J Parkar, A Ansari, A Vora, D Talwar… - International Journal of …, 2021 - Elsevier
Abstract The coronavirus disease-2019 (COVID-19) outbreak all over the world has led the
researchers to strive to develop drugs or vaccines to prevent or halt the progression of this …
researchers to strive to develop drugs or vaccines to prevent or halt the progression of this …
Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract
T Flerlage, DF Boyd, V Meliopoulos… - Nature Reviews …, 2021 - nature.com
Influenza viruses cause annual epidemics and occasional pandemics of respiratory tract
infections that produce a wide spectrum of clinical disease severity in humans. The novel …
infections that produce a wide spectrum of clinical disease severity in humans. The novel …
[HTML][HTML] Coronavirus RNA proofreading: molecular basis and therapeutic targeting
F Robson, KS Khan, TK Le, C Paris, S Demirbag… - Molecular cell, 2020 - cell.com
Summary The coronavirus disease 2019 (COVID-19) that is wreaking havoc on worldwide
public health and economies has heightened awareness about the lack of effective antiviral …
public health and economies has heightened awareness about the lack of effective antiviral …
Mild or moderate Covid-19
RT Gandhi, JB Lynch, C Del Rio - New England journal of …, 2020 - Mass Medical Soc
Key Clinical Points Mild or Moderate Covid-19 Covid-19 has a range of clinical
manifestations, including cough, fever, myalgias, gastrointestinal symptoms, and anosmia …
manifestations, including cough, fever, myalgias, gastrointestinal symptoms, and anosmia …
Extra-respiratory manifestations of COVID-19
CC Lai, WC Ko, PI Lee, SS Jean, PR Hsueh - International journal of …, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has become a global health threat. Although most …
syndrome coronavirus 2 (SARS-CoV-2), has become a global health threat. Although most …
Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review
JM Sanders, ML Monogue, TZ Jodlowski, JB Cutrell - Jama, 2020 - jamanetwork.com
Importance The pandemic of coronavirus disease 2019 (COVID-19) caused by the novel
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an …
A prospective, randomized, open-label trial of early versus late favipiravir therapy in hospitalized patients with COVID-19
Y Doi, M Hibino, R Hase, M Yamamoto… - Antimicrobial agents …, 2020 - Am Soc Microbiol
Favipiravir is an oral broad-spectrum inhibitor of viral RNA-dependent RNA polymerase that
is approved for treatment of influenza in Japan. We conducted a prospective, randomized …
is approved for treatment of influenza in Japan. We conducted a prospective, randomized …
Efficacy of antiviral therapies for COVID-19: a systematic review of randomized controlled trials
CTR Vegivinti, KW Evanson, H Lyons, I Akosman… - BMC Infectious …, 2022 - Springer
Abstract Background Coronavirus disease 2019 (COVID-19) continues to pose a significant
threat to public health worldwide. The purpose of this study was to review current evidence …
threat to public health worldwide. The purpose of this study was to review current evidence …
Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis
T Manabe, D Kambayashi, H Akatsu, K Kudo - BMC infectious diseases, 2021 - Springer
Background Favipiravir possesses high utility for treating patients with COVID-19. However,
research examining the efficacy and safety of favipiravir for patients with COVID-19 is …
research examining the efficacy and safety of favipiravir for patients with COVID-19 is …